Copyright
©The Author(s) 2024.
World J Gastroenterol. Oct 14, 2024; 30(38): 4194-4210
Published online Oct 14, 2024. doi: 10.3748/wjg.v30.i38.4194
Published online Oct 14, 2024. doi: 10.3748/wjg.v30.i38.4194
Figure 2 Emerging therapeutic strategies from Phase 2 trials in celiac disease treatment.
CCR9: C-C chemokine receptor type 9; IL: Interleukin; JAK3: Janus kinase 3.
- Citation: Massironi S, Franchina M, Elvevi A, Barisani D. Beyond the gluten-free diet: Innovations in celiac disease therapeutics. World J Gastroenterol 2024; 30(38): 4194-4210
- URL: https://www.wjgnet.com/1007-9327/full/v30/i38/4194.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i38.4194